Helping to Fund Medical Research since 1961 - DONATE NOW
Registered Charity No: 200843


NSMI Wade Conference Centre

2023 Spring Lecture

Professor Sir Martin Landray

Professor of Medicine and Epidemiology
University of Oxford

"Smarter randomised trials for better public health"

Tuesday 18th April 2023


Free Car Parking

Doors and Bar open at 5:15 pm
Lecture starts at 6:15 pm

Wade Conference Centre, Hartshill Road, Hartshill, Stoke on Trent, ST4 7NY

Ticket enquiries:

Telephone: 01782 714 888

or at the NSMI Wade Conference Centre Reception


Sir Martin Landray is Professor of Medicine & Epidemiology in Oxford Population Health at the University of Oxford, and Chief Executive of Protas, a not-for-profit company focused on the design and delivery of highly efficient randomized trials of treatments for major public health conditions. He has over 20 years' experience of leading trials of treatments for cardiovascular and kidney disease. Since March 2020, he has co-led the RECOVERY trial, enrolling over 48,000 patients with COVID-19 and publishing definitive results for 10 treatments which have changed clinical practice worldwide. He leads the Good Clinical Trials Collaborative that is developing and promoting the implementation of better guidelines and regulations for randomized trials. He was a lead contributor to the G7 Clinical Trials Charter and the 100 Days Mission for Pandemic Preparedness. In June 2021, he was knighted for services to public health and science.

Professor Landray’s work seeks to further understanding of the determinants of common diseases chiefly through the design, conduct and analysis of efficient, large-scale clinical trials. He has led a series of major clinical trials, chiefly of treatments for cardiovascular and kidney disease. The results of these trials have influenced regulatory drug approvals, clinical guidelines, and prescribing practice to the benefit of patients. Since March 2020, he has co-led the RECOVERY trial, the world’s largest trial of potential treatments for COVID-19, publishing definitive results for multiple treatments, including the discovery that dexamethasone reduces mortality for the sickest patients.

He leads Protas, a not-for-profit organisation focused on smarter randomised trials for better public health. He leads the Good Clinical Trials Collaborative in the development, promotion and adoption of guidelines for randomised controlled trials, supported by Wellcome and the Bill & Melinda Gates Foundation. In 2021, he was appointed to the Pandemic Preparedness Partnership leading to the publication of the G7 100 Days Mission to Respond to Future Pandemic Threats which recommended significant regulatory improvements to facilitate the rapid generation of relevant and robust results from innovative randomised controlled trials.

Professor Landray completed medical training at the University of Birmingham (UK) and specialist training in Clinical Pharmacology & Therapeutics and General Internal Medicine at the University of Birmingham. He continues to practise clinical medicine as an Honorary Consultant Physician in the Department of Cardiology at Oxford University Hospitals NHS Foundation Trust. In 2021 he was elected Fellow of the Academy of Medical Sciences and was knighted for services to public health and science.